Picture Not Available

Robert W. Mason, PhD

Contact Dr. Mason


,


Most Recent Peer-reviewed Publications

  1. Epidemiology of mucopolysaccharidoses
  2. Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII
  3. Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
  4. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses
  5. Mucopolysaccharidosis IVA and glycosaminoglycans
  6. Glycosaminoglycans detection methods: Applications of mass spectrometry
  7. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry
  8. Current therapies for Morquio A syndrome and their clinical outcomes
  9. Generation of pediatric leukemia xenograft models in NSG-B2m mice: Comparison with NOD/SCID mice
  10. Activity of daily living for Morquio A syndrome
  11. Cathepsin inhibition prevents autophagic protein turnover and downregulates insulin growth factor-1 receptor-mediated signaling in neuroblastoma
  12. Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
  13. Disruption of Annexin II /p11 interaction suppresses leukemia cell binding, homing and engraftment, and sensitizes the leukemia cells to chemotherapy
  14. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  15. Loss of Sip1 leads to migration defects and retention of ectodermal markers during lens development
  16. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses
  17. Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
  18. Morquio A syndrome: Diagnosis and current and future therapies
  19. Newborn screening and diagnosis of mucopolysaccharidoses
  20. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: A novel application in pediatric nanomedicine